SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

22 July 2008

 

PROTHERICS PLC

(Translation of Registrant’s Name Into English)

 

 

The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F       X              Form 40-F               

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):             

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):             

 

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under

the  Securities Exchange Act of 1934.

 

Yes                     No          X     

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-              .

 

 

The Registrant is furnishing a copy of its announcements as reported to the Company Announcements Office of the London Stock Exchange.

 

 


     
            

Protherics PLC

2008 Annual General Meeting Results

Lon don, UK; Brentwood, TN, US: 22 July 2008 - Protherics PLC (the “Company”), the international biopharmaceutical company focused on critical care and cancer, is pleased to announce that Resolutions 1 to 7 and 9 to 11 put forward at the Annual General Meeting of the Company held earlier today were passed. Since Resolution 7 was passed, Resolution 8 was withdrawn.
 
The proxy figures for the Resolutions are set out below and will shortly be displayed on the Company’s website at www.protherics.com .
 
 

Resolution Number (as noted on proxy form)

Shares For

Shares Discretionary

Shares Against

Shares Marked As Votes Withheld/ Abstentions

Poll
Yes/No

1

To receive the Financial Statements for the year ended 31 March 2007 together with the reports of the Directors and Auditors.

227,968,493

616,122

349,378

1,776

No

2

To elect R B Soderstrom as a Director.

228,087,050

613,554

172,810

62,355

No

3

To reappoint KPMG Audit Plc as Auditors of the Company.

228,114,010

624,117

190,689

6,953

No

4

To authorise the Directors to set the remuneration of the Auditors.

228,147,226

618,045

163,724

6,774

No

5

To approve the Directors’ Remuneration Report for the year ended 31 March 2008.

152,200,073

610,805

59,894,074

16,230,817

No

6

To authorise the Directors to allot shares pursuant to Section 80 of the Companies Act 1985 (the “Act”)

227,624,529

615,890

607,360

87,990

No

7

To authorise the Directors to disapply pre-emption rights pursuant to Section 95 of the Act (10%).

220,212,918

627,390

3,747,064

4,348,397

No

8

To authorise the Directors to disapply pre-emption rights pursuant to Section 95 of the Act (5%).

228,076,114

622,456

143,951

93,248

No

9

To receive and adopt the amended Articles of Association.

228,004,502

639,725

189,939

101,603

No

10

To approve and adopt the Protherics PLC 2008 Savings-Related Share Option Scheme.

228,181,154

625,467

97,992

31,156

No

11

To authorise the Directors to make amendments to the Protherics PLC 1996 unapproved Share Option Scheme

228,123,047

636,098

142,146

34,478

No



The full text of the resolutions together with the related Circular to Shareholders can be viewed at:

The Document Viewing Facility
The Financial Services Authority
25 The North Colonnade
Canary Wharf
London
E14 5HS

| Ends |

F or f urther i nformation please contact :

Protherics

 

Nick Staples, Director of Corporate Affairs

+44 (0) 7919 480510

Julie Vickers, Company Secretary

+44 (0)1928 518000

   

Financial Dynamics – press enquiries

 

London: Ben Atwell, Lara Mott

+44 (0) 20 7831 3113

New York: John Capodanno

+1 212 850 5600



Or visi t www.protherics.com

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

       

 

PROTHERICS PLC

       

Date: 22 July 2008

 

By:

 

/s/ Rolf Soderstrom

       

Rolf Soderstrom

       

Finance Director

 

 

Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Protherics Charts.
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Protherics Charts.